IOSP - INNOSPEC INC.
74.22
-2.800 -3.773%
Share volume: 156,032
Last Updated: 03-05-2026
Chemicals/Chemicals And Allied Products:
0.03%
PREVIOUS CLOSE
CHG
CHG%
$77.02
-2.80
-0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-10-2024 | 08-07-2024 | 11-06-2024 | 02-19-2025 | 05-09-2025 | 08-06-2025 | 11-05-2025 | 02-18-2026 | |
| Assets | |||||||||
| Total Assets | 1.733 B | 1.700 B | 1.798 B | 1.735 B | 1.775 B | 1.806 B | 1.799 B | 1.832 B | |
| Current Assets | 912.900 M | 876.800 M | 965.600 M | 956.600 M | 977.100 M | 969.700 M | 988.800 M | 1.005 B | |
| Inventories | 304.300 M | 313.500 M | 319.300 M | 301.000 M | 315.400 M | 336.800 M | 345.200 M | 329.300 M | |
| Other Current Assets | 900.000 K | 1.000 M | 600.000 K | 600.000 K | 1.400 M | 4.400 M | 4.100 M | 7.300 M | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 270.100 M | 240.200 M | 303.800 M | 289.200 M | 299.800 M | 266.600 M | 270.800 M | 292.500 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 268.700 M | 271.900 M | 278.200 M | 269.700 M | 277.100 M | 295.800 M | 278.600 M | 286.100 M | |
| Other Assets | 551.200 M | 551.600 M | 553.900 M | 508.400 M | 520.400 M | 540.600 M | 532.000 M | 541.700 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 1.733 B | 1.700 B | 1.798 B | 1.735 B | 1.775 B | 1.806 B | 1.799 B | 1.832 B | |
| Total liabilities | 546.600 M | 504.400 M | 550.100 M | 518.600 M | 508.900 M | 504.600 M | 496.500 M | 499.500 M | |
| Total current liabilities | 364.900 M | 332.800 M | 373.100 M | 371.400 M | 357.600 M | 337.400 M | 356.100 M | 360.100 M | |
| Accounts Payable | 166.400 M | 147.700 M | 169.000 M | 163.800 M | 169.500 M | 149.400 M | 162.200 M | 174.700 M | |
| Other liabilities | 55.900 M | 56.300 M | 58.200 M | 55.300 M | 58.200 M | 65.500 M | 49.300 M | 46.900 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 55.900 M | 56.300 M | 58.200 M | 55.300 M | 58.200 M | 65.500 M | 49.300 M | 46.900 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 1.184 B | 1.193 B | 1.243 B | 1.211 B | 1.260 B | 1.295 B | 1.297 B | 1.326 B | |
| Common stock | 362.700 M | 364.800 M | 366.900 M | 370.200 M | 371.000 M | 373.000 M | 373.900 M | 376.800 M | |
| Retained earnings | 1.070 B | 1.082 B | 1.115 B | 1.025 B | 1.058 B | 1.061 B | 1.073 B | 1.099 B |